CurvaFix Appoints Trevor Moody and Jeffrey Rydin to Board

Bellevue, Washington-based CurvaFix, Inc., has appointed two new members to its board of directors, Trevor Moody and Jeffrey Rydin.

Moody has over 25 years of medical technology experience. He is currently “a partner at M.H. Carnegie & Co., an Australian private equity and venture capital firm,” and president of TM Strategic Advisors LLC, a management consultancy company for medical technology companies. Previously, Moody was a general partner and co-led the medical device team at Frazier Healthcare Ventures.

Rydin has over 27 years of medical device and healthcare industry experience. He is currently a director of Alphatec Spine, Inc., a medical technology company focused on products for the surgical treatment of spine disorders, and DuraStat, LLC, a private company focused on dural repair. Previously, Rydin was the chief sales officer of Ellipse Technologies, Inc. and president of global sales at NuVasive, Inc.

“We’re honored to have Trevor and Jeffrey join our board at this exciting time in the development of our business,” says Steve Dimmer, CurvaFix’s CEO. “As we prepare for commercialization of the CurvaFix^® Intramedullary Rodscrew, these world-class executives are bringing their enthusiasm, broad strategy perspectives and oversight to our board.”

Dimmer continued, “Trevor is an accomplished business leader with extensive experience in development, commercialization and the funding of innovative, growth-oriented medical technologies. An experienced venture capital investor, Trevor has led or syndicated numerous capital financings. I am confident we will benefit substantially from his business acumen, insight and network.”

“Jeffrey’s broad commercial executive expertise includes having led sales efforts at Ellipse Technologies before its acquisition by NuVasive for $410M. Previously, he served as president of global sales at NuVasive where he successfully built the worldwide sales organization to an impressive $600M annually. His breadth of experience and demonstrated track record are sure to be assets for CurvaFix.”

CurvaFix is a privately held medical device company that develops “implantable products to improve fracture repair in curved bones.” The company’s first product is the CurvaFix^® Rodscrew, a “novel solution designed to improve outcomes and decrease costs for pelvic trauma patients.” The CurvaFix Rodscrew “is the only intramedullary implant capable of following the natural bone shape of curved bones such as the pelvis.” In 2019, the U.S. Food & Drug Administration (FDA) cleared the device for use in pelvic fracture treatment.

For OTW’s previous coverage of CurvaFix, see “First-in-Man for Novel Pelvic Fracture Rodscrew” and “FDA Clears Steerable Rodscrew for Pelvic Repair.”